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Loss of β-cell identity and diabetic phenotype in
mice caused by disruption of CNOT3-dependent
mRNA deadenylation
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Guy A. Rutter 3, Toru Suzuki 6✉ & Tadashi Yamamoto 1✉
Pancreatic β-cells are responsible for production and secretion of insulin in response to
increasing blood glucose levels. Defects in β-cell function lead to hyperglycemia and diabetes
mellitus. Here, we show that CNOT3, a CCR4–NOT deadenylase complex subunit, is dys-
regulated in islets in diabetic db/db mice, and that it is essential for murine β cell maturation
and identity. Mice with β cell-specific Cnot3 deletion (Cnot3βKO) exhibit impaired glucose
tolerance, decreased β cell mass, and they gradually develop diabetes. Cnot3βKO islets dis-
play decreased expression of key regulators of β cell maturation and function. Moreover, they
show an increase of progenitor cell markers, β cell-disallowed genes, and genes relevant to
altered β cell function. Cnot3βKO islets exhibit altered deadenylation and increased mRNA
stability, partly accounting for the increased expression of those genes. Together, these data
reveal that CNOT3-mediated mRNA deadenylation and decay constitute previously unsus-
pected post-transcriptional mechanisms essential for β cell identity.
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D iabetes mellitus is a metabolic disorder that is ultimatelycaused by the loss of functional pancreatic β cells1. Type 1diabetes (T1D) involves immune-mediated β-cell
destruction1, but dedifferentiation and dysfunction, rather than
β-cell loss per se, are implicated in the pathogenesis of type 2
diabetes (T2D)2. A fuller understanding of molecular mechan-
isms that govern β-cell differentiation, maturation, and dediffer-
entiation in T2D will likely prove crucial for developing novel
prevention and treatment strategies.
Pancreatic β cells are functionally defined by their capacity for
insulin secretion, stimulated by glucose and other nutrients3.
Underlying this unique function is a molecular identity defined
by expression of genes that drive β-cell maturation, insulin gene
expression, insulin granule formation, and exocytosis. Although
extensive research has focused on transcriptional and epigenetic
regulation of β-cell maturation and function, whether and how
post-transcriptional mechanisms influence β-cell gene expression
program have been little explored. Nonetheless, from pre-existing
mRNAs, glucose stimulates biosynthesis of insulin and other β-
cell proteins, particularly those involved in insulin granule bio-
genesis4. Furthermore, long non-coding RNAs (lncRNAs) and
micro-RNAs (miRNAs) act as important modulators of pan-
creatic β-cell gene expression and function5–7.
Most eukaryotic mRNAs are polyadenylated at the 3′ end, and
poly(A) tail lengths are important for post-transcriptional gene
regulation8. Importantly, mRNA deadenylation is the rate-
limiting step in mRNA decay9. Deadenylation shortens poly(A)
tail lengths, reducing the binding of cytoplasmic polyadenosine-
binding protein 1. This decreases mRNA stability, slowing
translation8. The CCR4–NOT complex constitutes the major
deadenylase complex in eukaryotes10,11. CCR4–NOT is a multi-
meric complex containing two catalytic subunits with dead-
enylase activity (CNOT6 or CNOT6L, and CNOT7 or CNOT8)
and six non-catalytic subunits (CNOT1, CNOT2, CNOT3,
CNOT9, CNOT10, and CNOT11)11. Although the exact func-
tions of the non-catalytic subunits remain elusive, they may
regulate stability and activity of the catalytic subunits and may
participate in recruitment of the CCR4–NOT complex to specific
target mRNAs12. Two targeting mechanisms have been proposed
to ensure specificity. First, sequence-specific RNA-binding pro-
teins (RBPs) bring the CCR4–NOT complex to sequence ele-
ments in the 3′ untranslated region of the target mRNA, and
second, the miRNA machinery recruits the CCR4–NOT complex
to its target mRNA13–15. Earlier studies have revealed the invol-
vement of the CCR4–NOT complex in development of metabolic
disorders such as obesity, diabetes, and lipodystrophy;16–18
however, its role in maintaining normal β-cell function has not
been investigated.
In this study, we examined whether and how mRNA dead-
enylation regulates β-cell function by analyzing the physiological
role of the CCR4–NOT complex in pancreatic β cells. We focused
on the CNOT3 subunit and we present evidence that CNOT3-
dependent deadenylation is pivotal for normal β-cell function.
We show that β-cell-specific knockout (KO) of Cnot3 results in
impaired glucose tolerance and ultimately the development of
overt diabetes. This might be attributable to a lack of β-cell
identity. Our data suggest that the observed β-cell dysfunction
can be partly explained by a loss of CNOT3-dependent control of
the decay of Aldob, Slc5a10, Wnt5b, and several other mRNAs
that are normally suppressed in β cells19-21. Thus, we propose
that CNOT3 is involved in degrading mRNAs from these genes to
maintain normal β-cell function. Our findings show that the
CCR4–NOT complex is deregulated in pancreatic islets in dia-
betes, thus suggesting that the CCR4–NOT complex serves as a
therapeutic target to treat diabetes.
Results
CNOT3 decreases in diabetic and gluco/lipo-toxic conditions.
We first asked whether CCR4–NOT complex subunit expression
is altered in the diabetic state. Accordingly, we isolated islets from
db/db mice, which lack the leptin receptor and develop severe
obesity associated with diabetes22. Immunoblot analysis revealed
a decrease in CCR4–NOT complex subunits, CNOT1, CNOT2,
and CNOT3 (Fig. 1a and Supplementary Fig. 1a, 2a) in diabetic
islets. Among these subunits, CNOT3 consistently showed a
marginally significant decrease in all samples examined (Sup-
plementary Fig. 1a and 2a). Since CNOT3 is an important subunit
of the CCR4–NOT complex17, these data suggest impaired
CCR4–NOT complex function in diabetic islets. To investigate
whether CCR4–NOT is a possible early effector in the patho-
genesis of diabetes, we examined CCR4–NOT complex subunit
expression in the prediabetic state using 20-week-old mice fed a
high-fat diet (HFD) for 3 months. We observed a significant
increase of CNOT8 (Fig. 1b and Supplementary Fig. 1b, 2b). In
order to determine whether these effects on CCR4–NOT complex
subunits were the result of gluco/lipotoxicity, we analyzed
CCR4–NOT subunit expression in MIN6 cells after chronic
exposure (1 week) to high glucose (50 mM), with or without
palmitic acid (500 µM). CNOT3 significantly decreased with high
glucose and palmitic acid treatments (Fig. 1c, Supplementary
Fig. 1c, 2c). CNOT8 increased with palmitic acid treatment in all
samples examined, although the extent of the increase varied
among samples (Fig. 1c, Supplementary Fig. 1c, 2c).
Impaired insulin secretion in Cnot3βKO mice. In light of the
above findings, we next investigated roles of the CCR4–NOT
complex in pancreatic β cells. We generated a mouse model
lacking the Cnot3 gene in β cells (Cnot3βKO mice). Successful
suppression of CNOT3 in β cells was confirmed by immunoblot
analysis and immunohistochemistry (Fig. 2a, b). Immunohis-
tochemistry revealed CNOT3 suppression in centrally located β
cells, while other islet cells located peripherally retained CNOT3
expression in Cnot3βKO islets. In mice, β cells make up the core
of the islets23, suggesting that CNOT3-expressing cells in
Cnot3βKO islets are non-β cells. Indeed, cells that did not
undergo Cre-mediated recombination, expressed glucagon
(GLUC), somatostatin (SST), and pancreatic polypeptide (PPT),
but not insulin, as shown in Fig. 3g. Consistent with CNOT3-
suppression in other tissues24–26, the abundance of other complex
subunits, such as CNOT1 and CNOT2, decreased in Cnot3βKO
islets (Supplementary Fig. 3a, b). Moreover, bulk poly(A) tail
analysis showed that the population of mRNAs with poly(A) tail
lengths longer than 50 nucleotides increased in Cnot3βKO islets,
compared with controls (Fig. 2c, d), indicating impairment of
deadenylase activity.
To determine whether CNOT3 depletion affects β-cell func-
tion, we conducted glucose tolerance tests (GTT) on control and
Cnot3βKO mice. We used 4- and 8-week-old mice. Four-week-
old Cnot3βKO mice showed glucose tolerance and fasting blood
glucose levels comparable to those of control mice (Fig. 2e).
While fasting blood glucose levels were still similar between 8-
week-old controls and Cnot3βKO mice, Cnot3βKO mice showed
impaired glucose tolerance (Fig. 2f). By the time Cnot3βKO mice
reached 12 weeks of age, they had developed overt diabetes, as
indicated by significant elevation of fasting blood glucose levels
(Fig. 2g). With development of overt diabetes, 12-week-old
Cnot3βKO mice displayed general deterioration of health and
clinical signs of diabetes, including polyuria, polydipsia, and
weight loss (Fig. 2h). These results suggest that metabolic
impairment worsened with age, supporting progressive loss of
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β-cell function in Cnot3βKO mice. Indeed, blood glucose levels in
8-week-old Cnot3βKO mice were significantly elevated above
those of control mice under normal feeding conditions (Fig. 2i).
Furthermore, we measured fasting serum insulin levels and serum
insulin levels after glucose administration in 8-week-old mice.
There was no significant difference in fasting serum insulin levels
between Cnot3βKO mice and controls. However, Cnot3βKO mice
had significantly lower serum insulin levels 15 min after glucose
administration, compared with controls (Fig. 2j). To evaluate β-
cell function, we performed a glucose-stimulated insulin secretion
(GSIS) assay on islets isolated from 8-week-old Cnot3βKO mice
and controls. Cnot3βKO islets displayed normal basal insulin
secretion at 3 mM glucose, but significantly decreased insulin
secretion upon stimulation with high (17 mM) glucose, compared
with control islets (Fig. 2k). This provides evidence for functional
impairment of Cnot3βKO islets. Results of this ex vivo assay also
agree with observed normal fasting serum insulin levels in
Cnot3βKO mice and decreased serum insulin after in vivo glucose
stimulation (Fig. 2j). Correspondingly, Cnot3βKO islets displayed
defective glucose-stimulated cytosolic Ca2+ dynamics, with a
markedly more rapid return of cytosolic Ca2+ to pre-stimulatory
levels in Cnot3βKO than in control islets (Fig. 2l, m). In contrast,
the fluorescent response of Cnot3βKO islets to depolarization
with KCl was marginally augmented from that of control islets,
consistent with the idea that observed β-cell dysfunction is largely
due to defects in glucose metabolism (Fig. 2n). Intercellular β–β
cell connectivity, adopting the Pearson correlation (R) analysis27
was not altered by Cnot3 deletion, when perfused with either high
glucose (17 mM) or KCl. Nevertheless, at low (3 mM) glucose, the
number of possible β cell–β cell connections decreased in
Cnot3βKO compared with control islets (Supplementary Fig. 4a,
b). No differences in connectivity strength between groups were
observed in response to high glucose or KCl (Supplementary
Fig. 4c, d).
Evaluation of 8-week-old Cnot3βKO mouse islet morphology
with H&E staining revealed pale nuclear staining with many
islets showing abnormal shapes. At 12 weeks of age, almost all
Cnot3βKO islets displayed abnormal shapes and neovascular-
ization. At 20 weeks of age, Cnot3βKO islets had reduced
numbers of cells in individual islets in a manner similar to that
observed in diabetic Goto-Kakizaki rats28 (Supplementary
Fig. 4e).
Reduced number of insulin-producing cells in Cnot3βKO mice.
β-cell-specific depletion of Cnot3 led to a significant reduction in
expression of murine insulin gene isoforms (Ins1 and Ins2)
(Fig. 3a). In order to trace Cnot3 depletion in β cells, we used
Ins1-Cre mTmG reporter mice, in which successfully recombined
cells show green fluorescence from expression of membrane-
targeted EGFP (mG), whereas unrecombined cells show red
fluorescence of membrane-targeted tdTomato (mT). Paraf-
ormaldehyde (PFA) fixation masks mTmG fluorescence, so in
order to trace successfully recombined cells we performed
immunofluorescence staining of EGFP. Immunofluorescence
staining of insulin and EGFP in control mice expressing Cre
recombinase (Control; +/Ins1-Cre) revealed successful labeling of
β cells with EGFP. Many EGFP-stained cells were insulin-nega-
tive, revealing a loss of insulin expression in many β cells in
Cnot3βKO islets (Fig. 3b, c). This was associated with a significant
reduction in insulin content in Cnot3βKO islets compared with
control islets (Fig. 3d). β-cell mass was reduced in Cnot3βKO
mice by nearly 50% (Fig. 3e). This was associated with smaller
islets, but not with a significant difference in islet number in
Cnot3βKO mice, compared with control mice (Fig. 3f). These
findings prompted us to determine whether decreased pancreatic
insulin content and reduced β-cell mass were driven by increased
β-cell death. We examined β-cell apoptosis by TUNEL assay.
Cnot3βKO islets did not show extensive TUNEL staining com-
pared with control islets (Supplementary Fig. 5).
In 8-week-old Cnot3βKO islets, many EGFP-stained cells
that were insulin-negative did not stain with anti-GLUC, anti-
SST, or anti-PPT antibodies, indicating that β cells did not
transform into other types of islet cells (Fig. 3g). Furthermore,
EGFP-stained cells in Cnot3βKO islets stained for the pan-
endocrine marker, synaptophysin (SYP), indicating that these
hormone-negative cells are viable and retain their endocrine
phenotype (Fig. 3h).
We further examined Cnot3βKO islets using transmission
electron microscopy (TEM) to detect any ultrastructural altera-
tions in β cells. Control islets possessed β cells with typical insulin
granules, manifesting characteristic electron-dense crystal cores,
and with β cell–β cell contacts displaying tight junctions essential
for normal insulin secretion29. In contrast, β cells from
Cnot3βKO islets were rather heterogeneous in appearance, with


















































Fig. 1 CCR4–NOT complex subunits are deregulated in mouse models of diabetes and obesity. a–c Immunoblot analysis of CCR4–NOT complex subunits
in: a islet lysates from 16-week-old +/db control and db/db mice. b islet lysates from 20-week-old mice fed a normal diet (ND) or a high-fat diet (HFD) for
12 weeks. c MIN6 cells under low/high-glucose conditions (LG/HG) with or without palmitic acid (PA) treatment. Each blot is a representative of three
different blots.
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degranulated with few, or abnormally small, insulin granules
(Fig. 3j, l). Also observed in Cnot3βKO islets were β cells with
atypical rod-shaped insulin granules, or with irregular plasma
membranes (Fig. 3i). We did not observe a significant difference
in numbers of mitochondria in control and Cnot3βKO islets
(Supplementary Fig. 6). The above findings suggest that diabetes
in Cnot3βKO mice is caused by both lack of β-cell identity, and
possibly by failure to achieve a fully differentiated state.
CNOT3 is essential for β-cell maturation and identity. Con-
sidering the above observations, we performed quantitative PCR
(qPCR) to measure expression of dedifferentiation/progenitor cell
markers. We observed significant upregulation of β-cell ded-
ifferentiation/progenitor cell markers, including Ngn3, Aldh1a3,
Myt1, Dcx, and Tnfrsf11b mRNAs (Fig. 4a). ALDH1A3 was
recently recognized as a marker of β-cell dedifferentiation in
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significant upregulation in islets isolated from Cnot3βKO mice,
compared with control islets (Fig. 4b, c, Supplementary Fig. 7).
This suggests that β cells in Cnot3βKO mice exhibit a progenitor-
like state.
In addition, we checked expression of a number of genes
critical for β-cell function. Among mRNAs encoding the
transcription factors important for β-cell function and insulin
transcription that we tested (Mafa, Nkx2.2, Nkx6.1, Neurod1 and
Pdx1), only Mafa mRNA was significantly reduced (Fig. 4d).
Mafa, is a key β-cell transcription factor and a driver of β-cell
maturation32 that was sharply reduced at the protein level as well
(Fig. 4e, Supplementary Fig. 8a). Consistent with decreased GSIS,
mass spectrometry (MS) analysis revealed significant reductions
in proteins involved in glucose sensing, insulin secretory granule
formation, and insulin secretion (Table 1). Some affected proteins
manifest no change in mRNA levels, while others were reduced,
but not significantly (Fig. 4d). We observed decreased expression
of glucose transporter-2 (GLUT2), in Cnot3βKO pancreata
(Fig. 4e, Supplementary Fig. 8b). GLUT2, encoded by the Slc2a2
gene, is a transmembrane protein involved in glucose uptake by β
cells, the first step of GSIS. In support of defective maturation of
CNOT3-depleted β cells, we found that urocortin 3 (Ucn3), a
marker of β-cell maturation, which is also important in GSIS33,
was unchanged at the mRNA level, but was strongly decreased at
the protein level (Fig. 4d, Table 1). Moreover, Cnot3βKO mice
displayed a post-transcriptional defect in insulin biosynthesis
where Cnot3βKO islets displayed significantly decreased expres-
sion of mRNAs encoding proteins involved in insulin biosynth-
esis, such as T2D-associated zinc transporter Slc30a8, proinsulin-
to-insulin convertase (Pcsk2), and carboxypeptidase (Cpe)34,35
(Fig. 4d and Table 1). These proteins have established roles in
insulin processing and/or maturation of insulin secretory
granules; thus, these data reveal loss of β-cell maturation markers
and defects in insulin biosynthesis.
In normal mature β cells, insulin secretion is regulated by
coupling glucose metabolism to insulin secretion36. Multiple
genes involved in glycolysis are upregulated in diabetes and
interfere with normal insulin secretion37. This prompted us to
investigate glycolytic enzyme mRNAs (Ldha, Hk1, and Hk2) with
other mRNAs that are normally repressed in mature β cells
(Slc16a1/Mct1, Rest and Pdgfra). Loss of their repression may
result in impaired β-cell function38. We observed significant
upregulation of Slc16a1, Ldha, and Hk2 mRNAs that belong to
the so-called β-cell-disallowed genes. Hk1, Rest, and Pdgfra
mRNAs were upregulated, but the increases were not statistically
significant (Fig. 4f). We confirmed the upregulation of MCT1,
LDHA, and HK1 at the protein level as well (Fig. 4g, h,
Supplementary Fig. 9, Table 1). These data support a metabolic
phenotype resembling that of immature/fetal β cells.
Transcriptome- and proteome-wide changes in Cnot3βKO
islets. To understand how loss of Cnot3 affects global gene
expression in β cells, we performed massive parallel RNA
sequencing (RNA-seq) of control and Cnot3βKO islets. Com-
parison of gene expression profiles between control and
Cnot3βKO islets revealed 3847 differentially expressed (DE) genes
(adjusted P < 0.05), of which 2234 genes were upregulated and
1613 genes were downregulated (Fig. 5a). To define the biological
processes affected by Cnot3 depletion, we performed gene
ontology (GO) analysis of DE genes using the DAVID gene
annotation tool (Fig. 5b). Consistent with the diabetic phenotype,
GO analysis showed that genes upregulated after Cnot3 depletion
are highly enriched for those involved in “immune system pro-
cess”, “lipid metabolic processes”, and “oxidation/reduction pro-
cesses”, while downregulated genes are highly enriched for those
involved in “regulation of insulin secretion” and “vesicle mediated
transport.” To gain more insight into the effect of Cnot3 depletion
on the pattern of gene expression in β cells, we applied a stricter
threshold by comparing the number of significantly upregulated
to downregulated genes that were DE by more than twofold.
Consistent with the molecular function of CNOT3 as a positive
modulator of CCR4–NOT-mediated mRNA decay, most genes
that exhibited more than twofold differential expression were
upregulated (Fig. 5c). We next examined whether changes in
Cnot3βKO islet transcriptomes are reflected in the corresponding
proteomes. We compared transcriptomic with proteomic data
from Cnot3βKO islets. There was a significant strong correlation
between DE genes and proteins in Cnot3βKO islets (R2= 0.64,
P < 2.2e−16), suggesting that most changes in the transcriptome
are mirrored in the proteome (Fig. 5d).
Steady-state mRNA abundance is mainly determined by rates
of RNA transcription and decay39. We used transcriptomic data
to infer mRNA stability in Cnot3βKO islets. While exonic read
counts in RNA-seq data correspond to steady-state mRNA
abundance, changes in abundance of intronic reads can be used to
estimate changes in transcription rate. We used this approach
to infer global mRNA stability from RNA-seq data. We estimated
the change in mRNA half-life as the difference of the logarithm
of the fold change in exonic reads and the logarithm of the
fold change in intronic reads (Δexon–Δintron)40. Because
CNOT3 is involved in mRNA deadenylation and subsequent
mRNA decay, we considered a transcript to be a target of CNOT3
if that transcript was upregulated and stabilized, as inferred from
RNA-seq data. We found that 80% of mRNAs (254 of 317) that
show increased Δexon–Δintron in Cnot3βKO compared with
control islets were among the significantly upregulated mRNAs,
suggesting that post-transcriptional mechanisms, including
mRNA stabilization, effectively contributed to an increase of
mRNAs in Cnot3βKO islets. In contrast, decreased intron reads in
Fig. 2 The loss of CNOT3 in β cells impairs glucose tolerance and causes diabetes. a Immunoblot analysis of CNOT3 in islet lysates from 8-week-old
control and Cnot3βKO mice. This blot is a representative of three different blots. b Immunofluorescence of CNOT3 (green) in islets from 8-week-old
control and Cnot3βKO mice. Nuclei were stained with DAPI (blue). A scale bar represents 50 µm. c Poly(A) tail lengths of global mRNAs by bulk poly (A)
assay in control and Cnot3βKO islets (n= 1, each sample was pooled from four mice). d Densitograms of poly(A) tail lengths shown in (c). Intraperitoneal
glucose tolerance tests in: e 4- and f 8-week-old control and Cnot3βKO mice (n= 6–9). g Fasting blood glucose in 12-week-old control (n= 5) and
Cnot3βKO mice (n= 4). h Body weight comparisons between control and Cnot3βKO mice at 4, 8 and 12 weeks of age (n= 6). i Blood glucose in 8-week-old
control (n= 6) and Cnot3βKO (n= 13) mice fed with ND. j Serum insulin in 8-week-old control and Cnot3βKO mice after 16 h fasting (0min) and 15 min
after glucose injection (2 g/kg body weight) (n= 4). k Insulin released by islets from 8-week-old control and Cnot3βKO mice in response to low 3mM
glucose (3G) and high 17 mM glucose (17G) stimulation for 1 h. This experiment is a representative of three independent experiments using three different
biological replicates (n= 3). Data are presented as mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001, two-tailed Student’s t test. l Cytosolic Ca2+ ([Ca2+]
cyt) responses in control (n= 20) and Cnot3βKO (n= 18) islets from three 8-week-old mice from each genotype in response to low (3G), high (17G)
glucose or 20mM KCl. m AUC of glucose-evoked Ca2+ traces. AUC was calculated using different baseline values for each group (0.95 for control and
1.03 for Cnot3βKO). n AUC of depolarizing stimulus, KCl, response. AUC was calculated using different baseline values for each group (1.15 for control and
0.95 for Cnot3βKO). Data are presented as mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001, Mann–Whitney test.
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Cnot3βKO islets were not relevant to any significant increase
of 63 mRNAs, despite increased Δexon–Δintron (Fig. 5e).
We compared upregulated, stabilized mRNAs in Cnot3βKO
islets to published RNA-seq data from db/db islets41 and found
73 upregulated, stabilized mRNAs to be upregulated in
db/db islets, suggesting that CNOT3 is involved in suppressing
diabetes-related genes (Supplementary Table 1). Interestingly,
transcriptome analysis revealed Aldob to be the most upregulated
(almost 1000-fold) stabilized mRNA. ALDOB is a glycolytic
enzyme that is normally silenced in mature β cells42,43. It was
dramatically upregulated at both the mRNA and protein levels
(Fig. 5f–h, Supplementary Fig. 11a). This dramatic upregulation
of Aldob mRNA is also possibly due to its increased transcription,
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Fig. 11b). In addition, the fructose/glucose transporter, Slc5a10,
and Wnt5b were among the most stabilized mRNAs, and they
were upregulated (Fig. 5f).
Increase of β cell-disallowed genes in Cnot3βKO islets. β cell-
disallowed genes are a group of genes that are normally abun-
dantly expressed in most tissues, but selectively repressed in β
cells21,44. Two previous studies identified 68 of such genes using
microarray analysis45,46. More recently, a novel study identified a
new list of β-cell-disallowed genes, based on RNA-seq data of
islets, β cells, and α cells19. We performed gene set enrichment
analysis (GSEA) of 61 β-cell-disallowed genes identified by the
latter study, which revealed enrichment of these β-cell-disallowed
genes in our transcriptome dataset (Fig. 6a, b).
We inferred the mRNA stability of some of these disallowed
genes together with Aldob, Slc5a10, and Wnt5b from transcrip-
tome analysis (Fig. 5e). Some mRNAs were filtered out in the
statistical analysis, due to the low expression values that hindered
assessment of their stability. We validated this stability analysis by
treatment of control and Cnot3βKO islets with Act D and
determined their relative abundances at 4-h intervals. Aldob,
Wnt5b, Cat, and Abtb2 mRNAs were significantly stabilized
(Fig. 6c). On the other hand, other upregulated mRNAs: Hk1,
Rest, and Yap1 were not stabilized, indicating that some mRNAs
increased independent of mRNA stabilization (Fig. 6c). We could
not assess the stability of Slc5a10, Slc16a1, Ldha, and Pdgfra
experimentally. Yet, based on statistical evaluation of exon and
intron counts, we found that among these mRNAs, Slc5a10
(logFC= 4.76, FDR= 1.7e−17) was stabilized.
To exclude the possibility that the observed immature
phenotype is merely caused by hyperglycemia, we performed
experiments on euglycemic 4-week-old Cnot3βKO mice. We
observed significant downregulation of Mafa, Ins1, and Ins2
mRNAs, and significant upregulation of Aldob, Slc5a10, Wnt5b,
Hk1, and Tnfrsf11b mRNAs, suggesting that the molecular defect
results directly from the loss of Cnot3, rather than to
hyperglycemia (Supplementary Fig. 12).
To further understand the mechanism by which CNOT3 alters
mRNA stability, we asked whether affected genes interact with
CNOT3. To answer this question, we carried out RNA
immunoprecipitation (RIP) using MIN6 cell line lysates with an
antibody specific for CNOT3 and negative control immunoglo-
bulin G (IgG). RNA from total extracts (Input), IgG, and
CNOT3-immunoprecipitated samples were analyzed by qPCR.
Among β cell-disallowed genes analyzed, Slc16a1, Ldha, Cat,
Abtb2, Fgf1, Igfbp4, Acot7, and Cxcl12 mRNAs were significantly
enriched in CNOT3-immunoprecipitated samples, compared
with IgG immunoprecipitated samples (Fig. 6d). These data
suggest that the above genes interact with CNOT3. Interestingly,
Yap1 is a β cell-disallowed gene that did not interact with CNOT3
(Fig. 6d) and its mRNA decay rate was not affected in Cnot3βKO
mice (Fig. 6c). This observation implies that Yap1 upregulation
after Cnot3 deletion is an indirect effect (possibly on transcrip-
tion) rather than a result of reduced decay. In summary, our data
suggest that Cnot3 depletion resulted in decreased mRNA decay
rates and increased protein synthesis of target transcripts.
Discussion
The loss of β-cell identity and dedifferentiation are increasingly
recognized as contributors to impaired β-cell function in T2D2. β-
cell maturation involves increased expression of β-cell-specific
genes as well as repression of genes that would interfere with
normal β-cell function, so-called β-cell “disallowed” genes3,45–47.
Involvement of post-transcriptional control in regulation of those
genes will provide novel insights into β-cell functional maturation
and pathogenesis of diabetes. Our findings suggested that
CCR4–NOT complex-dependent mRNA deadenylation is crucial
for regulation of β-cell-specific genes and disallowed genes, and
consequently for β-cell maturation (Fig. 7). Consistent with this, a
disruption of the CCR4–NOT complex might be pathogenic in
diabetes.
The process of GSIS in mature β cells is regulated primarily by
levels of extracellular glucose. Unlike immature β cells, which
secrete insulin under low-glucose conditions, mature β cells
secrete insulin in response to increases in blood glucose, thus
maintaining normal glucose homeostasis without causing hypo-
glycemia42. Here, we show that both GSIS and glucose-stimulated
cytosolic Ca2+ dynamics were impaired in Cnot3βKO mice,
suggesting impaired glucose metabolism. Impaired glucose
metabolism could be due to decreased GLUT2 expression and
defects in maturity. Expression of glycolytic genes, such as Hk1,
Hk2, and Ldha, is sharply downregulated during β-cell matura-
tion42,48. We observed increased expression of these glycolytic
genes and other markers of immature β cells (Slc16a1, Rest, and
Pdgfra). Ectopic expression of Hk1, Slc16a1, and Ldha reportedly
impairs glucose metabolism and GSIS38,49,50. Moreover,
decreased expression of Pdgfra during maturation results in
decreased proliferation of mature β cells, necessary for normal
GSIS51.
β-cell-disallowed genes are selectively silenced in functional β
cells. Their repression, which ensures normal GSIS44, is an ele-
ment of β-cell identity, acquired during postnatal maturation.
The molecular mechanisms involved in repressing these genes are
largely unknown; thus, it is currently unclear whether there is a
single silencing mechanism for all disallowed genes, or whether
several molecular mechanisms are involved. Previous report
suggested that epigenetic mechanisms such as DNA methylation
are involved in repressing several disallowed genes (Pdgfra, Acot7,
Igfbp4 and Fgf1)43. Significantly, DNA methylation is generally
essential for β-cell maturation and contributes to repression of
Fig. 3 The lack of CNOT3 in β cells reduces insulin expression. a qPCR analysis of insulin mRNA isoforms (Ins1 and Ins2), normalized to the Gapdh mRNA
level, in control and Cnot3βKO islets (n= 7). b Co-immunofluorescence staining of EGFP (green), insulin (magenta) and DAPI (blue) in pancreatic sections
from 8-week-old control and Cnot3βKO mice. A scale bar represents 25 µm. Representative results from three 8-week-old mice from each genotype are
shown. c Quantification data of immunofluorescence analysis presented in Fig. 3b. Each data point represents %EGFP+ in Insulin+ β cells in control and
Cnot3βKO islets (n= 12) from three 8-week-old mice from each genotype. d Insulin content of islets from 8-week-old control (n= 4) and Cnot3βKO (n=
5) mice. e β-cell mass measurement in pancreatic sections from 8-week-old control and Cnot3βKO mice (n= 4). f Islet number per pancreas area in
pancreatic sections from 8-week-old control and Cnot3βKO mice (n= 4). g Co-immunofluorescence staining of EGFP (green), insulin (magenta), GLUC
(blue), SST (blue) and PPT (blue) in pancreatic sections from 8-week-old mTmG reporter: “control (Cnot3+,+; +/Ins1-Cre) and Cnot3βKO”mice. A scale bar
represents 25 µm. h Co-immunofluorescence staining of EGFP (green), insulin (magenta) and SYP (blue) in pancreatic sections from 8-week-old mTmG
reporter: “control (Cnot3+,+; +/Ins1-Cre) and Cnot3βKO” mice. A scale bar represents 25 µm. Representative results from three 8-week-old mice from each
genotype are shown. i–l Transmission electron microscopy performed on islets isolated from 8-week-old control and Cnot3βKO mice (n= 3), including
quantification of j vesicle density, k vesicle diameter and l the percentage of mature (black bar) and immature vesicles (white bar). A scale bar represents
1 µm. Data are presented as mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001, two-tailed Student’s t test.
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immature genes, including Aldob, Hk1, Hk2, and Ldha42. Histone
methylation may also be involved where trimethylation of histone
H3 on lysine 27 (H3K27me3), was found in the promoter regions
of Slc16a1, Cxcl12, Acot7, Nfib, Mgst1, and Maf44,52. Importantly,
miRNAs downregulate Slc16a1, Acot7, Fcgrt, Igfbp4, Maf, Oat,
and Pdgfra, implicating post-transcriptional mechanisms in reg-
ulation of disallowed genes7,53,54. The CCR4–NOT complex uses
miRNAs to recognize target mRNAs13,14. It is conceivable that
the CCR4–NOT complex is involved in miRNA-dependent reg-
ulation of β-cell-disallowed genes.
Nearly all processed eukaryotic mRNAs possess poly (A) tails at
their 3′ ends. Generally, mRNAs with longer poly (A) tails are more
stable than mRNAs with shorter poly (A) tails8. Suppression of any
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target mRNAs, due to elongated poly (A) tails24,25,55. In our study,
insufficient deadenylation observed in Cnot3βKO islets (Fig. 2c, d),
is coincident with upregulation and stabilization of mRNAs,
including Aldob, Slc5a10, and Wnt5b (Fig. 5f). Increased expression
of Aldob and Slc5a10 is associated with decreased insulin secre-
tion37,56, suggesting their contribution to impaired GSIS. Impor-
tantly, upregulation of Aldob, Slc5a10, and Wnt5b mRNAs is
correlated with diabetes37,56–58. These results agree with our pre-
vious findings that the CCR4–NOT complex is involved in reg-
ulation of energy metabolism genes15–18. This study provides
evidence that the CCR4–NOT complex is involved in repressing
Aldob, Slc5a10, Wnt5b, and several disallowed genes through both
direct and indirect mechanisms. We showed that Cnot3 KO results
in upregulation and increased stability of Aldob, Slc5a10, Wnt5b,
Cat, and Abtb2 mRNAs (Fig. 6c). The finding that CNOT3 directly
interacts with Wnt5b, Cat, and Abtb2 mRNAs (Fig. 6d) suggests
direct repression of these genes by the CCR4–NOT complex.
On the other hand, suppression of CNOT3 is likely to have
indirect effects on gene expression partly through expression
changes in key transcription factors. We and others have recently
reported that Mafa, Pax6, Rfx6, and Nkx2.2 act as repressors of
several disallowed genes, and changes in any of these factors may
be involved in upregulation of disallowed genes32,59–61. Among
these repressors, Mafa was significantly decreased in Cnot3βKO
islets (Fig. 4d, e). Therefore, it is possible that decreased Mafa in
Cnot3βKO islets contributes to increased expression of disallowed
genes. Downregulation of Mafa could also explain upregulation of
endocrine progenitor cell markers observed in Cnot3βKO.
Upregulation of these progenitor markers, as a result of Mafa
downregulation, indicates a failure to attain a fully differentiated
state in β cells and upregulates β-cell-disallowed genes32. Indeed,
Slc16a1 was upregulated, but not stabilized. Thus, we propose
that Slc16a1 is upregulated indirectly by CNOT3 through Mafa
repression. This agrees with its upregulation observed in ded-
ifferentiated β cells of Mafa KO mice32. The Mafa suppression
mechanism was not determined in this study. Taken together, our
data and those of others suggest that repression of disallowed
genes is achieved by multiple mechanisms.
Our findings raise the possibility that disruption of the
CCR4–NOT complex could be involved in the loss of β-cell identity
in diabetes, possibly through de-repression of β-cell immature and
disallowed genes. We observed decreased expression of CNOT3 in
db/db mice islets. Moreover, glucotoxicity and lipotoxicity sig-
nificantly reduced CNOT3 levels in MIN6 cells. This agrees with
proteomic analysis of human islets that revealed significant reduc-
tion of CNOT3 during high-glucose treatment62. In addition,
enrichment of immune-related mRNAs among the upregulated
mRNAs in Cnot3βKO islets suggests an involvement of enhanced
immune response in impaired β cells. It should be noted that
enhanced immune response is observed in mouse tissues lacking
CCR4–NOT complex function, such as liver and adipose tis-
sues16,18,55,63. In our model, we cannot determine whether the
increased immune response in Cnot3βKO mice is a cause or a
consequence of β-cell dysfunction. Nevertheless, our findings sug-
gest possible relationship between CCR4–NOT complex dysfunc-
tion and diabetes (both T1D and T2D). This requires further study
including participation of human diabetes patients.
Several lines of evidence have shown that the loss of
CCR4–NOT complex subunits results in serious abnormalities in
embryonic development and tissue function10. Importantly, the
CCR4–NOT complex contributes to maintenance of both plur-
ipotency of embryonic stem cells and tissue function/identity via
mRNA deadenylation. The CCR4–NOT complex promotes the
decay of mRNAs that are relevant to immature tissue state, cell
death, and proliferation to ensure differentiation or normal tissue
development16,24,55. In contrast, the CCR4–NOT complex
decreases mRNAs responsible for differentiation to maintain
pluripotency64–66. Therefore, the CCR4–NOT complex con-
tributes to proper mRNA expression by decreasing unnecessary
mRNAs depending on the context. The difference in mRNA-
binding proteins that recruit the CCR4–NOT complex to target
mRNAs could explain its diverse functions. It is also possible that
tissue-specific RBPs compete with the interaction of the
CCR4–NOT complex with particular mRNAs, as in the case of
HuR and miRNA-induced silencing complex67. Global under-
standing of target mRNA recognition of the CCR4–NOT complex
depending on the context will help to delineate the molecular
basis of tissue-specific CCR4–NOT complex function.
In conclusion, our work identifies CNOT3 as an important
post-transcriptional regulator of β-cell identity and function,
Fig. 4 CNOT3 is essential for β-cell maturation and identity. a qPCR analysis of progenitor cells/dedifferentiation markers, normalized to the Gapdh
mRNA level, in control and Cnot3βKO islets (n= 4–6). b Immunoblot analysis of ALDH1A3 in islet lysates from 8-week-old control and Cnot3βKO mice.
This blot is a representative of three different blots. c Band quantification of an immunoblot of ALDH1A3 (n= 3) in Fig. 4b. d qPCR analysis of β-cell-
specific functional mRNAs expression categorized as β-cell-specific transcription factors, glycolytic pathway, insulin granule maturation, and insulin
secretion mRNAs, normalized to the Gapdh mRNA level, in control and Cnot3βKO islets (n= 3–7). e Co-immunofluorescence staining of MAFA (green),
GLUT2 (green), and insulin (magenta) in pancreatic sections from 8-week-old control and Cnot3βKO mice. A scale bar represents 25 µm. Representative
results from four 8-week-old mice from each genotype are shown. f qPCR analysis of immature β-cell markers, normalized to the Gapdh mRNA level, in
control and Cnot3βKO islets (n= 5–7). g Immunoblot analysis of MCT1 and LDHA in islet lysates from 8-week-old control and Cnot3βKO mice. This blot is
a representative of three different blots. h Band quantification of immunoblot of MCT1 and LDHA (n= 3). Data are presented as mean ± SEM; *P < 0.05;
**P < 0.01; ***P < 0.001, two-tailed Student’s t test.
Table 1 Categories of proteins affected by Cnot3 KO in β cells obtained from MS analysis of Cnot3βKO islets.
Category Protein symbol
Glycolysis GCK (FC= 1, P= 0.4), G6PC2 (FC= 1.6, P= 0.13)
Insulin granule feature VAMP2 (FC= 0.6, P= 0.01), SLC30A8 (FC= 0.4, P= 0.049), SYTL4 (FC= 0.9, P= 0.4), PC1 (FC= 0.48,
P= 0.09), PC2 (FC= 0.58, P= 0.007), CPE (FC= 0.3, P= 0.002)
Glucose sensing and Insulin
secretion
GLUT2 (FC= 0.4, P= 0.1), GLP1R (FC= 0.58, P= 0.0007), UCN3 (FC= 0.4, P= 0.02)
β cell disallowed ACOT7 (FC= 1.55, P= 0.1), HK1 (FC= 2, P= 0.003), ALDOC (FC= 3.1, P= 0.02), LDHA (FC= 1.89, P= 0.04)
Affected β-cell markers are in bold.
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and raises the possibility that alterations in CNOT3 expression
and/or dysregulation of the CCR4–NOT complex contribute to
β-cell failure in diabetes. It further raises the possibility
that CNOT3 might offer a promising therapeutic target to
protect β-cell function or to generate β cells for treatment of
diabetes.
Methods
Mice. To suppress Cnot3 expression in β cells, we crossed mice carrying Cnot3
floxed alleles (Cnot3flox/flox)16,26 with Ins1-Cre mice (Riken Bioresource Center,
# RBRC09525), in which Cre recombinase is knocked in at the Ins1 locus68.
Recombination is expected to be restricted largely to β cells, and to be minimal at
other sites, including the brain, where Ins1 is not expressed69. mTmG reporter mice
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mediated recombination was induced. Primers used for genotyping are listed in
Supplementary Table 2. β-cell-specific Cnot3 KO mice (Cnot3βKO) were used for
experiments, and their littermates (Cnot3flox/flox) were used as controls, unless
otherwise stated (Ins1-Cre mice were used as controls for Cnot3βKO expressing
mTmG reporter gene). All experiments were performed on 8–10-week-old male
mice, unless stated otherwise. db/db mice were used as a model of T2D22 and
compared with +/db mice, purchased from CLEA Japan. We maintained mice on a
12-h light/dark cycle in a temperature-controlled (22 °C) barrier facility with free
access to water and either a normal chow diet (NCD, CA-1, CLEA Japan) or a HFD
(HFD32, CLEA Japan). All mouse experiments were approved by the Animal Care
and Use Committee of Okinawa Institute of Science and Technology (OIST)
Graduate University, Okinawa, Japan.
Islet isolation. Pancreata were perfused with Collagenase P (Sigma) by injection in
the common hepatic bile duct at a concentration of 1 mg/mL in Hank’s buffered
salt solution (HBSS) medium (Invitrogen) supplemented with 1% bovine serum
albumin, BSA (Roche). Pancreata were then removed and dissociated in a 37 °C
water bath for 16 min. Dissociated pancreata were passed through a metal sieve to
remove undigested tissue chunks, followed by washing in HBSS supplemented with
0.1% BSA. Islets were then separated onto a gradient of Histopaque 1077 (Sigma)
overlaid with RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin–streptomycin (10,000 U/mL, Gibco). Afterward,
islets were collected from the boundary of Histopaque 1077 and RPMI 1640 and
passed through a 70-μm cell strainer into a cell culture dish with RPMI
1640 supplemented with 10% FBS and 1% penicillin/streptomycin, from which
islets were hand-picked for experiments to avoid contamination with exocrine
tissue.
Cell lines. MIN6 (mouse insulinoma-6) β-cell line, a well-established model for the
study of β-cell function, was used for some in vitro investigations70. MIN6 cells
were obtained from Dr. Susumu Seino, Kobe University Graduate School of
medicine. MIN6 cells were cultured in high-glucose Dulbecco’s modified Eagle’s
medium (Wako) supplemented with 10% FBS and 1% penicillin–streptomycin. For
induction of glucotoxic stress, the glucose concentration was increased to 50 mM
by dissolving glucose in culture medium followed by sterile filtration.
Fatty acid solution preparation and MIN6 cell line treatment. Palmitate stock
solution was prepared by dissolving palmitate (Sigma P9767) in 50% ethanol at
70 °C to a final concentration of 100 mM. The stock solution was then diluted in
culture medium with 0.5% BSA to a final concentration of 0.5 mM. Palmitate was
allowed to complex with BSA for 30 min at 37 °C before being added to the cells.
Cells not treated with palmitate were treated in the same manner, but palmitate
stock solution was replaced with vehicle (50% ethanol).
Immunoblot analysis. Pancreatic islets and MIN6 cells were lysed using TNE lysis
buffer (1% NP-40, 50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM
phenylmethylsulfonylfluoride, 10 mM NaF). All immunoblot analyses were done
following SDS-PAGE standard protocols except for MCT1 and LDHA. We could
not detect them by conventional western blotting and used automated Simple Wes
system (ProteinSimple) for their detection.
We used an automated Simple Wes system, according to the manufacturer’s
instructions with a 12–230 kDa Separation Module (ProteinSimple SM-W004) and
the Anti-Rabbit Detection Module. Four microliters of islet lysate was combined
with 1 µL Fluorescent Master Mix and heated at 95 °C for 5 min. The biotinylated
ladder, samples, antibody diluent, primary antibodies (in antibody diluent), HRP-
conjugated secondary antibodies, and chemiluminescent substrate were pipetted
into the plate (part of the Separation Module). Instrument default settings were
used: stacking and separation at 375 V for 25 min; blocking reagent for 5 min,
primary and secondary antibody both for 30 min; Luminol/peroxide
chemiluminescence detection for ~15 min. Details of primary and secondary
antibodies used are listed in Supplementary Tables 3 and 4, respectively.
Glucose tolerance tests. Mice were fasted for 16 h, followed by fasting blood
glucose measurement using blood samples taken from the tail vein. Mice were then
injected intraperitoneally with glucose (2 g/kg body weight) and blood glucose was
measured in tail vein blood samples at 15, 30, 60, and 90 min using the Glutest Pro
glucometer (Sanwa Kagaku Kenkyusho, Japan).
GSIS assay in vivo. Mice were fasted for 16 h, followed by blood sample collection
from a facial vein to evaluate serum insulin levels under no glucose stimulation.
Mice were then injected intraperitoneally with glucose (2 g/kg body weight) and
blood samples were collected from the facial vein 15 min post-glucose injection.
Blood samples were allowed to clot in vacutainer tubes (BD Japan) at room
temperature followed by centrifugation for 10 min at 4000 rpm and separation of
serum. Serum insulin levels were measured using an ultrasensitive mouse insulin
ELISA kit (Takara).
GSIS assay on islets ex vivo. Ten islets were pre-cultured in 450 µL Krebs Ringer
buffer (KRB) (140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 2 mM NaHCO3, 1.5
mM CaCl2, 0.5 mM MgSO4, 10 mM HEPES, 0.25% BSA), pH= 7.4, containing 3
mM glucose for 1 h in open Eppendorf tubes. Supernatants were discarded and
replaced with 450 µL KRB containing either 3 mM or 17 mM glucose for 1 h.
Supernatants were collected after 1 h. Finally, islets were treated with 1 mL 1.5%
HCl in ethanol and homogenized by sonication three times (30 s on/off). Acid/
ethanol lysates were then centrifuged. Supernatants were collected to measure
insulin content and residual islet fragments were used for DNA extraction. Insulin
in KRB supernatant (released insulin) and islet lysates (islet insulin content) was
measured using an ultrasensitive mouse insulin ELISA kit (Takara). Both released
insulin and islets insulin content were normalized to islet DNA content.
Measurement of intracellular free calcium (Ca2+). Functional multicellular
Ca2+-imaging was performed on isolated islets previously incubated with Cal-520
acetoxymethyl (AM; 2 µM; Stratech) for 45 min at 37 °C in KRB supplemented
with 3 mM glucose. Fluorescent imaging was performed using a Zeiss Axiovert
microscope equipped with a 10–20×/0.3–0.5 NA objective, a Hamamatsu image-
EM camera coupled to a Nipkow spinning disk head (Yokogawa CSU-10). Volocity
software (PerkinElmer Life Sciences) provided the interface. Islets were kept at
37 °C and constantly perfused with KRB-containing 3 mM, 17 mM glucose or
20 mM KCl. For each experiment, ~20 islets were used, isolated from 3 animals per
genotype. Imaging data were analyzed with ImageJ software using an in-house
macro (available upon request). Fluorescent traces (F) were normalized to baseline
recorded under 3 mM glucose (Fmin). The AUC at 17 mM glucose was calculated
using different fluorescence baseline values (prior perfusion with high glucose) for
each genotype group. The same approach was adopted to measure the AUC during
KCl imaging, where baseline values prior to stimulation with KCl were used.
Pearson (R)-based connectivity and correlation analyses. Correlation analyses
between the Ca2+ signal time series for all cell pairs of an imaged islet were
performed in MATLAB using a modified custom-made script from the one pre-
viously described27. Briefly, a noise reduction function (effectively a rolling aver-
age) was applied to smooth noisy data and all traces were normalized to minimum
(basal) fluorescence (Fmin). The correlation function R between all possible
(smoothed) cell-pair combinations (excluding the autocorrelation) was assessed
using the Pearson’s correlation. Data are displayed as heatmap matrices, indicating
individual cell-pair connections on each axis (min.= 0; max.= 1). Cartesian co-
ordinates of imaged cells were then taken into account, while constructing con-
nectivity line maps. Cell pairs were connected with a straight line, the color of
which represented the correlation strength, based on a color-coded light–dark
ramp (R= 0.1–0.25 [blue], R= 0.26–0.5 [green], R= 0.51–0.75 [yellow], R=
0.76–1.0 [red]). Positive R values (excluding auto-correlated cells) and the per-
centage of cells that were significantly connected to one another were averaged and
compared between groups.
Fig. 5 Global gene expression changes in Cnot3βKO islets. a 3847 genes were differentially expressed (DE) in islets following CNOT3 depletion in β cells.
The graph indicates the percentage distribution of genes differentially expressed (P < 0.05) in Cnot3βKO compared with control islets (n= 3, each sample
was pooled from two mice). Multidimensional scaling (MDS) plot is presented in Supplementary Fig. 10. b GO analysis of mRNAs significantly upregulated
(red) and downregulated (blue) in Cnot3βKO islets. Bar charts of GO terms (Biological Process) ranked by FDR (<0.05) are shown. Gene lists included in
each GO term are summarized in Supplementary Data 1. c Volcano plot of DE genes indicating the percentage distribution of DE (P < 0.05) genes by more
than twofold upregulation (red) or downregulation (blue). d Pearson correlation analysis between differentially expressed genes and proteins identified by
RNA-seq analysis and MS analysis of control and Cnot3βKO islets. e Venn diagram showing the overlap of significantly upregulated (red) and stabilized
(green) mRNAs in Cnot3βKO compared with control islets. f qPCR analysis of three top upregulated and stabilized mRNAs (Aldob, Slc5a10 and Wnt5b),
normalized to the Gapdh mRNA level, in control and Cnot3βKO islets (n= 3–6). g Immunoblot analysis of ALDOB in islet lysates from 8-week-old control
and Cnot3βKO mice (n= 3). This blot is a representative of three different blots. h Band quantification of immunoblot of ALDOB (n= 3). Data are
presented as mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001, two-tailed Student’s t test.
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Fig. 6 Derepression of β cell-disallowed genes and their mRNA stabilization in Cnot3βKO islets. a GSEA of β-cell-disallowed genes, identified in Pullen
et al.19, in Cnot3βKO islets. b Heatmap of 30 disallowed genes showing mRNA expression obtained from RNA-seq analysis of control and Cnot3βKO islets.
c Decay curves of the indicated mRNAs. Total RNA was prepared from control and Cnot3βKO islets treated with Act D for 0, 4, or 8 h. Relative mRNA
levels were determined by qPCR and normalized to the Gapdh mRNA level. mRNA levels without Act D treatment (0 h) were set to 100% (n= 3). d RIP-
qPCR in MIN6 cells using normal anti-mouse and anti-CNOT3 antibodies revealing the interaction of CNOT3 with the indicated mRNAs that adversely
affect β cell function (n= 3). Data are presented as mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001, two-tailed Student’s t test.
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Immunohistochemistry and immunofluorescence. All immunohistochemistry
was performed on pancreatic sections from control and Cnot3βKO mice, except for
CNOT3 immunofluorescence staining, which was performed on control and
Cnot3βKO islets.
Pancreatic section preparation and Immunohistochemistry: Pancreata were fixed
overnight in 4% PFA phosphate-buffered solution (Wako) at room temperature.
They were then transferred to 70% ethanol and subsequently embedded in paraffin
and sectioned at 3 μm. Some sections were stained with H&E. Other sections were
used for immunofluorescence. All sections for immunofluorescence underwent
dewaxing with xylene and rehydration with ethanol (100%, 95%, 70%, and 50%) by
incubation for 3 min at room temperature. Antigen retrieval was performed using
10 mM sodium citrate buffer, pH= 6, at 120 °C in a pressure cooker for 10 min.
Once sections cooled to room temperature, tissue samples were blocked with
blocking buffer (2% BSA solution in phosphate-buffered saline (PBS) and 0.05%
Tween) for 30 min to 1 h at room temperature. Samples were then incubated with
primary antibodies overnight at 4 °C. On the following day, samples were
incubated with secondary antibodies for 1–2 h in the dark at room temperature. A
TUNEL assay was performed using an In Situ Cell Death Detection Kit, TMR red
(Roche), following the manufacturer’s protocol.
Immunofluorescence staining of CNOT3: Islets were fixed in 4% PFA phosphate-
buffered solution (Wako) for 10 min at room temperature. Then samples were
washed twice in PBS for 5 min. Residual PFA was quenched by incubation with
100 mM glycine for 10 min at room temperature, followed by two washes with PBS.
Islets were then permeabilized in 0.5% Triton-X-100 for 5 min at room
temperature and rinsed twice with PBS. Islets were blocked with blocking buffer
and incubated with primary and secondary antibodies in the same manner as
described for pancreatic sections. Finally, samples were incubated with Ultra Cruz
hard-set mounting medium with DAPI (Santa Cruz). Details of primary and
secondary antibodies used are listed in Supplementary Tables 5 and 6, respectively.
Morphometric image analysis. All immunohistochemistry/immunofluorescence
images were acquired using a Leica confocal microscope (TCS SP8 Leica). All
images were processed using Fiji (www.fiji.sc) and Imaris (v.2.9) softwares. To
calculate β-cell mass, pancreatic sections were stained with insulin (β-cell area).
Then, β-cell area was divided by total pancreatic area and multiplied by pancreatic
weight (mg).
Transmission electron microscopy. We fixed islets in 2.5% glutaraldehyde in 0.1
M cacodylate buffer (pH 7.4) for 30 min at room temperature. After three washes
with 0.1 M cacodylate buffer, islets were fixed in 1% cacodylate-buffered osmium
tetroxide for 1 h at room temperature, then dehydrated in a graded ethanol series,
and embedded in epoxy resin. Ultrathin sections (50 nm) of islets were cut with a
diamond knife, placed on copper grids, and stained with 4% uranium acetate for
30 min and then with Sato’s lead staining solution. Samples were examined using a
JEOL JEM-1230R TEM.
RNA extraction and quantitative PCR. Total RNA was extracted from islets or
MIN6 cells with Isogen II, according to the manufacturer’s protocol (Nippon
Gene). RNA purity and concentration were evaluated by spectrophotometry using
a NanoDrop ND-2000 (Thermo Fisher). The quality of RNA was assessed using an
Agilent 2100 Bioanalyzer microfluidics-based platform (Agilent Technologies,
Inc.). To measure mRNA stability, islets were treated with Act D (5 μg/mL), a
transcription inhibitor, and total RNA was extracted at the indicated time points
and subjected to qPCR. Total RNA (1 μg) was used for reverse transcription with
oligo(dT)12–18primer (Invitrogen) using the SuperScript III First-Strand Synthesis
System (Invitrogen). qPCR reactions were carried out using TB Green Premix Ex
Taq (Takara) and the ViiA 7 Real-Time PCR System (Applied Biosystems). Gapdh
mRNA levels were used for normalization. Relative mRNA expression was deter-
mined by ΔΔCT method. Primers used for qPCR reactions are listed in Supple-
mentary Table 7.
Bulk poly(A) tail assay. Bulk poly(A) tail assay was conducted as previously
described. Total RNA (2 µg) was labeled with [5′-32P] pCp (cytidine 3′,5′-bis
[phosphate]) (0.11 pmol/μL in a total reaction volume of 30 μL) (PerkinElmer;
NEG019A) using T4 RNA ligase 1 (NEB, M0204S) at 16 °C overnight. Labeled
RNAs were incubated at 85 °C for 5 min and placed on ice. Then, labeled RNAs
were digested with Ribonuclease A (50 ng/μL, Sigma) and Ribonuclease T1 (1.25 U/
μL, Thermo Fisher Scientific) at 37 °C for 2 h in digestion buffer (100 mM
Tris–HCl [pH 7.5], 3 M NaCl, 0.5 μg/mL yeast tRNA). Reactions were stopped by
adding 5× stop solution (10 mg/mL Proteinase K, 0.125M EDTA, 2.5% SDS) and
subsequently incubating at 37 °C for 30 min. After adding 400 μL of RNA pre-
cipitation buffer (0.5 M NH4OAc, 10 mM EDTA), digested RNA samples were
purified by phenol–chloroform extraction and isopropanol precipitation. Final




Impaired β cell maturation
Insufficient insulin release
Diabetic phenotype
β cell disallowed/immature mRNA
β cell maturation mRNA (e.g. Mafa)
CCR4-NOT complex
Fig. 7 A schematic model of role of CCR4–NOT complex-mediated deadenylation in β-cell maturation. CNOT3, one key subunit of the CCR4–NOT
complex, is required for proper function of the CCR4–NOT complex. CNOT3 (Green oval) regulates expression of some β-cell-disallowed/immature genes,
possibly through CCR4–NOT complex-mediated mRNA decay. Therefore, Cnot3 KO in β cells impairs β-cell maturation due to failure to repress β-cell-
disallowed/immature genes.
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incubated at 95 °C for 2 min. Samples were fractionated on an 8M urea-10%
polyacrylamide denaturing gel (0.8 mm thick). Marker (Prestain Marker for small
RNA Plus, BioDynamics Laboratory DM253) was also loaded. The gel was ana-
lyzed with a Typhoon FLA 9500 Fluorescence Imager (GE Healthcare). Band
intensity was quantified using ImageJ.
RNA sequencing. RNA-seq was performed by the next-generation sequencing
section at OIST Graduate University. Hundred nanograms of total RNA was used
for RNA-seq library preparation with a TruSeq Stranded mRNA Library Prep Kit
for NeoPrep (NP-202-1001; Illumina) that allows polyA-oligo(dT)-based pur-
ification of mRNA. The manufacturer’s protocol was employed with minor
modification and optimization as follows. Custom dual index adapters were ligated
at the 5′ and 3′-end of libraries, and PCR was performed for 11 cycles. One
hundred fifty-base-pair paired-end read RNA-seq was performed with a Hiseq
3000/4000 PE Cluster Kit (PE-410-1001; Illumina) and a Hiseq 3000/4000 SBS Kit
(300 Cycles) (FC-410-1003; Illumina) on a Hiseq4000 (Illumina), according to the
manufacturer’s protocol.
Bioinformatic processing of RNA-seq data. Paired-end RNA-seq data were
mapped to the Mus musculus reference strain mm10 UCSC using StrandNGS,
next-generation sequencing analysis software. Counts for each sample were
imported into the R statistical environment. Genes without an expression level of at
least one read per million mapped reads in at least three samples were removed
before differential-gene expression testing between control, and Cnot3βKO islet
RNA replicates, using the edgeR function in the Bioconductor package edgeR.
Genes that were DE with an FDR adjusted P value (padj) <0.05 were considered
statistically significant and included in enrichment testing. We identified GO terms
enriched among significantly upregulated and downregulated genes using the
DAVID annotation tool (https://david.ncifcrf.gov/). GO terms were considered
significantly enriched if they had an FDR value < 0.05.
Sample preparation for proteomic analysis. Samples were prepared for liquid
chromatography/mass spectrometry (LC/MS) using the phase-transfer surfactant
method, with minor modifications. First, proteins were extracted from islets and
solubilized using buffer containing 12 mM sodium deoxycholate, 12 mM sodium
N-dodecanoylsarcosinate, and 100 mM Tris pH 9.0, with EDTA-free Protease
Inhibitor Cocktail (Roche, Switzerland). Islet samples were sonicated for 10 min
using a Bioruptor (Cosmo Bio, Japan) on high power with 1-min on/1-min off
cycles. Cell debris was removed after centrifugation at 18,000 × g for 20 min at 4 °C.
Protein concentrations were adjusted to a uniform concentration for a set of
samples (0.5–1.0 μg/μL), and between 5 and 20 μg protein was used for peptide
preparation. Cysteine–cysteine disulfide bonds were reduced with 10 mM dithio-
threitol at 50 °C for 30 min. Free thiol groups were alkylated with 40 mM iodoa-
cetamide in the dark at room temperature for 30 min. Alkylation reactions were
quenched with 55 mM cysteine at room temperature for 10 min. Samples were
diluted with 2.76 volumes of 50 mM ammonium bicarbonate. Lysyl endopeptidase
(Wako, Japan) and trypsin (Promega, USA) were added at a 50:1 ratio of sample
protein:enzyme (w/w) and samples were digested for 14 h at 37 °C. Afterward, 1.77
volumes ethyl acetate were added, and samples were acidified with trifluoroacetic
acid (TFA), which was added to 0.46% (v/v). Following centrifugation at 12,000 × g
for 5 min at room temperature, samples separated into two phases. The upper
organic phase containing sodium deoxycholate was removed, and the lower aqu-
eous phase containing digested tryptic peptides was dried using a centrifugal
vacuum concentrator. Digested peptides were dissolved in 300 µL of 0.1% (v/v)
TFA in 3% acetonitrile (v/v) and samples were desalted using MonoSpin C18
columns (GL Sciences Inc., Japan). Peptides were eluted from C18 columns using
0.1% TFA in 50% acetonitrile and dried in a vacuum concentrator. Tryptic peptides
were dissolved in 0.1% (v/v) formic acid in 3% (v/v) acetonitrile for MS analysis.
MS measurement. Samples were measured using a Q-Exactive Plus Orbitrap
LC–MS/MS System (Thermo Fisher Scientific, USA), equipped with a Nanospray
Flex ion source. The same amount of peptide was injected for each sample in a
given set of samples, which was typically 300–600 ng in a volume of 2 to 5 µL.
Peptides were separated on a 3-µm particle, 75-µm inner diameter, 12-cm filling
length C18 column (Nikkyo Technos Co., Ltd, Japan). A flow rate of 300 nL/min
was used with a 2-h gradient (1–34% solvent B in 108 min, 34–95% solvent B in 2
min, with a final wash at 95% solvent B for 10 min, where solvent A was 0.1% (v/v)
formic acid in LC/MS grade water and solvent B was 0.1% (v/v) formic acid in 80%
(v/v) acetonitrile). The mass spectrometer ion transfer tube temperature was 250 °C
and 2.0 kV spray voltage was applied during sample measurement.
For data-dependent acquisition (DDA), full MS spectra were acquired from 380
to 1500m/z at a resolution of 70,000. The AGC target was set to 3e6 with a
maximum injection time (IT) of 100 ms. MS2 scans were recorded for the top 20
precursors at 17,500 resolution with an AGC of 1e5 and a maximum IT of 60 ms.
The first mass was fixed at 150m/z. The default charge state for the MS2 was set to
2. HCD fragmentation was set to normalized collision energy of 27%. The intensity
threshold was set to 1.3e4, charge states 2–5 were included, and dynamic exclusion
was set to 20 s.
For data-independent acquisition (DIA), data were acquired with 1 full MS and
32 overlapping isolation windows constructed covering the precursor mass range of
400–1200 m/z. For full MS, resolution was set to 70,000. The AGC target was set to
5e6 and maximum IT was set to 120 ms. DIA segments were acquired at 35,000
resolution with an AGC target of 3e5 and an automatic maximum IT. The first
mass was fixed at 150m/z. HCD fragmentation was set to normalized collision
energy of 27%.
Protein identification and quantification. Raw files from DDA measurements
were searched against the Uniprot mouse database using Proteome Discoverer
v2.2 software (Thermo Fisher Scientific, USA). Digestion enzyme specificity was set
to Trypsin/P. Precursor and fragment mass tolerance were set to 10 ppm and 0.02
Da, respectively. Modification included carbamidomethylation of cysteine as a fixed
modification, with oxidation of methionine and acetyl (protein N-terminus) as
variable modifications. Up to two missed cleavages were allowed. A decoy database
was included to calculate the FDR. Search results were filtered with FDR 0.01 at
both peptide and protein levels. Filtered output was used to generate a sample-
specific spectral library using Spectronaut software (Biognosys, Switzerland). Raw
files from DIA measurements were used for quantitative data extraction with the
generated spectral library. FDR was estimated with the mProphet approach71 and
set to 0.01 at both peptide precursor level and protein level72. Data were filtered
with FDR < 0.01 in at least half of the samples.
RNA immunoprecipitation. RIP was done on MIN6 cells using anti-CNOT3
antibody (generated by immunizing mice in cooperation with Bio Matrix
Research Incorporation). MIN6 cells, 80% confluent in 10-cm dishes were lysed
with 1 mL TNE buffer per dish. MIN6 cell lysates were then incubated with 1 µg
of either anti-CNOT3 or control IgG antibody in an upside-down tumbling
manner for 1 h at 4 °C, and then incubated with 40 μL of protein G Dynabeads
(Invitrogen) in an upside-down tumbling manner for 2 h at 4 °C. Later, beads
were separated using a magnetic rack and washed five times with TNE buffer.
RNAs in immune complexes were isolated using Isogen II, and cDNA was
generated with SuperScript Reverse Transcriptase III followed by qPCR.
Abundance of each mRNA is quantified as % of input mRNA. Then mRNA
bound to anti-CNOT3 antibody was presented as fold change relative to mRNA
bound to control IgG antibody.
Statistics and reproducibility. Differences between groups were examined for
statistical significance using the Student’s t test (two-tailed distribution with two-
sample equal variance), Mann–Whitney test, or One-way ANOVA. Analyses were
performed using GraphPad Prism (GraphPad Software v.8.0), RStudio (v.1.1.453)
and GSEA (v.4.0.1) developed by Broad Institute (http://software.broadinstitute.
org/gsea/index.jsp). A P value of < 0.05 was considered statistically significant.
Sample sizes and number of replicates are indicated in figure legends.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All source data underlying the graphs and charts presented in the main and
supplementary figures are presented in Supplementary Data 1. Raw transcriptomic data
sets described in the current study are available through ArrayExpress under accession
number E-MTAB-8729. Mass spectrometric proteomics data have been deposited in the
ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identifier PXD018403.
Code availability
The scripts used for differential expression analysis of RNA-seq data and mRNA stability
analysis are provided in the Supplementary Information file. The script used for mRNA
stability analysis was previously published in ref. 40 and can be accessed via this link:
https://static-content.springer.com/esm/art%3A10.1038%2Fnbt.3269/MediaObjects/
41587_2015_BFnbt3269_MOESM34_ESM.tar. We also deposited all the scripts we used
and their data files in GitHub: https://github.com/Dina-Mostafa/Scripts-for-differential-
gene-expression-analysis.
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